Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Friedreich's Ataxia
100%
Frataxin
43%
Guanine
40%
RNA
40%
Nonsense-Mediated Decay
32%
Fibroblast
30%
Reprogramming
26%
Deep Sequencing
24%
Exon
20%
Stop Codon
20%
Genome-Wide Association Study
20%
DNA Synthesis
20%
Mitochondrial DNA
20%
Adenine
20%
Mitochondrial Genome
20%
Repressor
20%
T Cell Receptor
20%
Brachyury
20%
PAX3
20%
Genotyping
20%
Mutational Load
20%
Enhancer Region
20%
Transcription Elongation
20%
Blood Plasma
20%
DNA Methylation
20%
Transcription
13%
Messenger RNA
12%
Genetic Carrier
12%
Heterozygote
12%
Neural Crest
12%
Zinc Finger Nuclease
12%
Gene Expression
10%
Intron
10%
Downregulation
10%
KCNJ4
10%
Codon
10%
Genomics
10%
DNA Damage
8%
Single Nucleotide Polymorphism
8%
Histone Modification
8%
CpG Island
8%
Malignant Transformation
8%
Nuclear Membrane
7%
Nuclear Pore
7%
Induced Pluripotent Stem Cell
6%
RNA Sequence
6%
Autosomal Recessive Inheritance
6%
Gene Frequency
5%
Nucleoplasm
5%
Keyphrases
Malignant Peripheral Nerve Sheath Tumor (MPNST)
45%
Undifferentiated Pleomorphic Sarcoma
42%
Regulatory Switch
20%
UPF3
20%
Enhancer Reprogramming
20%
Repeat Expansion
20%
Insulin-like
20%
Spina Bifida
20%
Polycomb Repressor Complex 2
20%
Growth Factors
20%
Conotruncal
20%
Academic Cancer Center
20%
Small Molecule Inhibitors
20%
A1 Receptor
20%
Dedifferentiated
20%
Neurofibromatosis Type I
20%
Neurofibromatosis Type 1 (NF-1)
20%
Nonsense-mediated Decay
20%
Cancer Prevalence
20%
Exon Sequencing
20%
Brachyury
20%
RNA Surveillance
20%
Mammalian Target of Rapamycin (mTOR)
20%
Co-target
20%
DNA Replication Fork
20%
Friedreich Ataxia
20%
GAA Repeats
20%
Pax3
20%
UPF3B
17%
Tumor
15%
UPF3A
15%
Neoplasms
13%
Neural Crest
12%
Sarcoma
12%
Phosphoinositide 3-kinase (PI3K)
10%
Novel Variants
8%
Frataxin
8%
Cellular Models
8%
Tumorigenic Potential
8%
Subcutaneous Injection
8%
Tumor Implantation
8%
Disease-specific Survival
7%
Putative Drug Targets
7%
Xenograft
7%
Sarcoma Cells
6%
Soft Tissue Sarcoma
6%
Public Database
5%
Common Variants
5%
Neurofibroma
5%
Regulatory Mechanism
5%
Medicine and Dentistry
Malignant Peripheral Nerve Sheath Tumor
45%
Connective Tissue Cancer
42%
Neurofibromatosis Type I
40%
Neoplasm
36%
Spinal Dysraphism
20%
Mammalian Target of Rapamycin
20%
Exon
20%
Somatomedin C Receptor
20%
Population
20%
Malignant Neoplasm
20%
Prevalence
20%
Biological Marker
20%
DNA Methylation
20%
Phosphoinositide 3-Kinase
15%
Cell Line
12%
Mechanistic Target of Rapamycin
10%
Xenograft
10%
Sarcoma Cell
10%
Disease Specific Survival
9%
Plexiform Neurofibroma
7%
In Vitro
7%
Cancer
7%
Gene Frequency
6%
Ganglioglioma
5%
Receptor
5%
Protein Kinase B
5%
Cell Invasion
5%
Cell Migration
5%
Tumor Progression
5%
Cellular Model
5%
Cell Proliferation
5%
Subcutaneous Injection
5%
Implant
5%
Phosphotransferase Inhibitor
5%
Mammalian Target of Rapamycin Inhibitor
5%
Antiproliferative Activity
5%
